Correlation Between Genenta Science and Pharvaris

Can any of the company-specific risk be diversified away by investing in both Genenta Science and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genenta Science and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genenta Science SpA and Pharvaris BV, you can compare the effects of market volatilities on Genenta Science and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genenta Science with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genenta Science and Pharvaris.

Diversification Opportunities for Genenta Science and Pharvaris

0.58

Correlation Coefficient

Genenta Science  Pharvaris

Very weak diversification

The 3 months correlation between Genenta and Pharvaris is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Genenta Science SpA and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Genenta Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genenta Science SpA are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Genenta Science i.e., Genenta Science and Pharvaris go up and down completely randomly.

Pair Corralation between Genenta Science and Pharvaris

Given the investment horizon of 90 days Genenta Science SpA is expected to generate 1.6 times more return on investment than Pharvaris. However, Genenta Science is 1.6 times more volatile than Pharvaris BV. It trades about -0.04 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.12 per unit of risk. If you would invest  488.00  in Genenta Science SpA on December 27, 2024 and sell it today you would lose (75.00) from holding Genenta Science SpA or give up 15.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Genenta Science SpA  vs.  Pharvaris BV

Genenta Science SpA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Genenta Science SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Genenta Science and Pharvaris

The main advantage of trading using opposite Genenta Science and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genenta Science position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.

The idea behind Genenta Science SpA and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.